HUTCHMED (China) Limited

The current price of HCM is $15.16 — it has increased by 6.76% since the previous close. Data as of Nov 6, 2026.

HCM is up 14.59% over the past week, up 6.16% over the past month and up 1.40% over the past year. The price is above its 200-day moving average of $13.18.

Analysts' average 12-month price target for HCM is $22.78, which implies 50.26% upside from the current price. Individual estimates range from $13.60 to $45.00.

Of the 12 analysts covering HUTCHMED (China) Limited, 1 rates it a strong buy, 9 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

HUTCHMED (China) Limited has a market capitalization of $2.64B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, HUTCHMED (China) Limited posted earnings of $0.046 per share against an estimate of $0.145, missing expectations by 68.28%. Upcoming reports are listed in the earnings calendar.

HUTCHMED (China) Limited reported revenue of $278.29M in its most recent quarter, which has increased by 0.21% compared with the same quarter a year earlier. Analysts had expected $304.16M.

HUTCHMED (China) Limited has not paid any dividends over the past year.

In the latest trading session HCM moved between $14.44 and $15.31, a range of 5.74% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of HUTCHMED (China) Limited shows a strong buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for HUTCHMED (China) Limited is buy. Technical ratings are indicators, not investment advice.

Over the past 52 weeks HCM has traded between $9.77 and $16.33. The current price is 7.16% below its 52-week high.